Evidence-based, actionable monitoring information to optimise drug treatment

Drug Monitoring Checker is an essential tool to support healthcare professionals make effective drug monitoring decisions at the point of care.

Authored in collaboration with external experts, Drug Monitoring Checker provides clear, concise, and actionable advice before, during and after treatment.

Contact Sales Content Updates
Use case content image

Tailored for use in primary and secondary care settings, the Drug Monitoring Checker provides:

  • Clear rationale
  • Defined frequencies
  • Indication-specific monitoring advice
  • Parameter Profiles to guide interpretation of results
  • Evidence-graded recommendations to aid decision-making
  • Actionable advice for abnormal results
  • Time-saving, easy to search guidance
  • Multiple routes of administration
image above stats

Learn how to monitor a patient with severe hypertension, using new practical information and guidance available through MedicinesComplete

 

Download patient case study

 

150+

drug specific monographs

20+

parameter profiles

Updated

monthly

Publication Updates

14 Jun
Drug Monitoring Checker June 2022 Update

This update contains 4 new monographs, and 9 minor updates.

New monographs: Acebutolol; Celiprolol hydrochloride; Metoprolol tartrate; Nebivolol

Minor updates: Bendroflumethiazide; Chlortalidone; Dronedarone; Eplerenone; Indapamide; Spironolactone; Atenolol; Bisoprolol fumarate; Propranolol hydrochloride

10 May
Drug Monitoring Checker May 2022 Update

This update contains 4 new monographs, and 15 minor updates.

New monographs: Amphotericin B; Co-amoxiclav; Flucloxacillin; Phenoxymethylpenicillin

Minor updates: Amiodarone hydrochloride; Atorvastatin; Apixaban; Dabigatran; Digoxin; Edoxaban; Fluvastatin; Heparin; Pravastatin sodium; Rivaroxaban; Rosuvastatin; Simvastatin; Dalteparin sodium; Enoxaparin sodium; Tinzaparin sodium

11 Apr
Drug Monitoring Checker April 2022 Update

This update contains 7 new monographs and 8 minor updates.

New monographs: Ceftriaxone; Clindamycin; Gentamicin; Rifampicin; Teicoplanin; Trimethoprim; Vancomycin

Minor updates: Ciclosporin; Fusidic acid; Metronidazole; Minocycline; Mycophenolate; Nitrofurantoin; Tacrolimus; Atorvastatin

08 Mar
Drug Monitoring Checker March 2022 Update

This update contains 5 new monographs, 9 new parameter profiles, and 13 minor updates.

New monographs: Dosulepin Hydrochloride; Doxepin; Imipramine Hydrochloride; Nortriptyline; Amikacin.

New parameter profiles: Calcitonin; Free thyroxine (FT4); Free triiodothyronine (FT3); Thyroglobulin; Thyroid antibodies; Thyroid function tests; Thyroid-stimulating hormone; Thyroxine (T4); Triiodothyronine (T3).

Minor updates: Amitriptyline; Azathioprine; Ciclosporin; Citalopram; Escitalopram; Hydroxychloroquine Sulfate; Leflunomide; Methotrexate; Mycophenolate Mofetil; Penicillamine; Sulfasalazine; Tacrolimus; Venlafaxine.

08 Feb
Drug Monitoring Checker February 2022 Update

This update contains 4 new monographs and 1 minor update.

New monographs: Aciclovir; Azithromycin; Glimepiride; Glipizide.

Minor updates: Warfarin